LPC

Lion Point Capital Portfolio holdings

AUM $14.7M
This Quarter Return
+17.47%
1 Year Return
+16.78%
3 Year Return
+52.25%
5 Year Return
+189.95%
10 Year Return
–
AUM
$14.7M
AUM Growth
+$14.7M
Cap. Flow
-$6M
Cap. Flow %
-40.74%
Top 10 Hldgs %
74.34%
Holding
21
New
–
Increased
–
Reduced
2
Closed
2

Top Buys

No buys this quarter

Top Sells

1
MCRB icon
Seres Therapeutics
MCRB
$3.6M
2
INSM icon
Insmed
INSM
$2M
3
BLUE
bluebird bio
BLUE
$385K
4
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
$21.8K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FENC icon
1
Fennec Pharmaceuticals
FENC
$247M
$1.62M 11.03% 195,700 – –
ARDX icon
2
Ardelyx
ARDX
$1.53B
$1.31M 8.93% 335,400 – –
KNSA icon
3
Kiniksa Pharmaceuticals
KNSA
$2.48B
$1.27M 8.62% 45,900 – –
BBIO icon
4
BridgeBio Pharma
BBIO
$9.89B
$1.12M 7.62% 26,000 – –
INSM icon
5
Insmed
INSM
$28.8B
$1.07M 7.28% 10,650 -19,850 -65% -$2M
MLYS icon
6
Mineralys Therapeutics
MLYS
$1.03B
$1.07M 7.26% 79,000 – –
MIST icon
7
Milestone Pharmaceuticals
MIST
$156M
$1.06M 7.23% 548,806 – –
AVDL
8
Avadel Pharmaceuticals
AVDL
$1.43B
$873K 5.93% 98,700 – –
JSPR icon
9
Jasper Therapeutics
JSPR
$45.5M
$813K 5.52% 146,500 – –
BNTC icon
10
Benitec Biopharma
BNTC
$348M
$725K 4.93% 62,000 – –
GERN icon
11
Geron
GERN
$893M
$705K 4.79% 500,000 – –
ARQT icon
12
Arcutis Biotherapeutics
ARQT
$1.86B
$649K 4.41% 46,300 – –
IRON icon
13
Disc Medicine
IRON
$2.07B
$561K 3.81% 10,600 – –
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.41B
$515K 3.5% 55,000 – –
RGNX icon
15
Regenxbio
RGNX
$451M
$474K 3.22% 57,750 – –
BHVN icon
16
Biohaven
BHVN
$1.63B
$320K 2.17% 22,700 – –
MRSN icon
17
Mersana Therapeutics
MRSN
$36.5M
$191K 1.29% 644,000 – –
MCRB icon
18
Seres Therapeutics
MCRB
$166M
$189K 1.29% 17,038 -323,723 -95% -$3.6M
HUMA icon
19
Humacyte
HUMA
$245M
$175K 1.18% 83,500 – –
BLUE
20
DELISTED
bluebird bio
BLUE
– – -78,912 Closed -$385K
SPRB
21
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
– – -75,000 Closed -$21.8K